SCHEMBL6192033

SCHEMBL6192033

O[C@@H](COc1ccccc1F)CC1CNCCN1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 5/20 0.42
HTR7 P34969 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
LTA4H P09960 1/20 0.39
SLC6A2 P23975 8/20 0.38
SLC6A3 Q01959 4/20 0.38
SLC6A4 P31645 3/20 0.38
SSTR4 P31391 2/20 0.38
POLB P06746 1/20 0.37
MAN2A1 Q16706 1/20 0.36
MAN1B1 Q9UKM7 1/20 0.36
HPGD P15428 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6195071 0.87 KDM4E (0.34) HTR1AHTR7KDM4EKMT2ALTA4H
SCHEMBL6193610 0.85 LMNA (0.52) KDM4EALDH1A1KMT2ALTA4HSLC6A2
SCHEMBL7280306 0.82 LTA4H (0.51) KDM4ELTA4HCYP2D6
SCHEMBL15645465 0.80 LTA4H (0.55) HTR1ALTA4HSLC6A2SLC6A3SLC6A4
SCHEMBL15645462 0.80 LTA4H (0.55) HTR1ALTA4HSLC6A2SLC6A3SLC6A4
SCHEMBL5901643 0.70 POLB (0.70) HTR1AALDH1A1KMT2APOLB
SCHEMBL5995987 0.70 POLB (0.70) HTR1AALDH1A1KMT2APOLB
SCHEMBL10432963 0.70 CYP1A2 (0.64) HTR1AHTR7KDM4EALDH1A1KMT2A
SCHEMBL773168 0.69 ALOX15 (0.61) HTR1AHTR7KDM4EALDH1A1KMT2A
SCHEMBL6449880 0.68 LTA4H (0.43) KDM4ELTA4HCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583751-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES CV THERAPEUTICS, INC. (US) 2005-10-12 EP disclosed
WO-2004069818-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES CV THERAPEUTICS INC. (US) 2004-08-19 WO disclosed